For research use only. Not for therapeutic Use.
AUN97411(Cat No.: I022671) is an experimental small molecule inhibitor currently under preclinical evaluation for its anticancer properties. It is designed to target and modulate a specific signaling pathway implicated in tumor cell proliferation and survival. By interfering with key molecular interactions, AUN97411 aims to suppress tumor growth and metastasis while minimizing off-target effects. Early studies indicate potential efficacy and a favorable safety profile, warranting further investigation into its therapeutic applications. Additional research will determine its viability as a next-generation targeted cancer therapy.
| CAS Number | 1496997-41-1 |
| Synonyms | 5,6-Difluoro-thalidomide; AUN97411; AUN-97411; AUN 97411; |
| Molecular Formula | C13H8F2N2O4 |
| Purity | 98% |
| Target | Autophagy |
| Solubility | To be determined |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | 2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoro-2,3-dihydro-1H-isoindole-1,3-dione |
| InChI | InChI=1S/C13H8F2N2O4/c14-7-3-5-6(4-8(7)15)13(21)17(12(5)20)9-1-2-10(18)16-11(9)19/h3-4,9H,1-2H2,(H,16,18,19) |
| InChIKey | AGHXYRKTAZEQQW-UHFFFAOYSA-N |
| SMILES | O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=C(F)C(F)=C3)=O |
